Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 70, Issue 3, 2008, Pages 845-852

  Liu, Xiao Bin ^a   Ye, Jun Xiao ^a   Quan, Li Hui ^a   Liu, Chun Yu ^a   Deng, Xu Liang ^b   Yang, Ming ^c   Liao, Yong Hong ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b PEKING UNIVERSITY   (China)

^c JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Flavonoids; Hyaluronan; Intratracheal spray; Intravenous delivery; Mucociliary transport; Peroral delivery; Pulmonary delivery; Scutellarin

Indexed keywords

EXCIPIENT; FLAVONOID; SCUTELLARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG PENETRATION; FEASIBILITY STUDY; FIRST PASS EFFECT; FROG; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MUCOCILIARY CLEARANCE; NONHUMAN; RAT; SPRAY DRYING;

ADHESIVENESS; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; AEROSOLS; ANIMALS; APIGENIN; BIOLOGICAL AVAILABILITY; BUFONIDAE; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DRUGS, CHINESE HERBAL; EXCIPIENTS; FEASIBILITY STUDIES; GLUCURONIC ACIDS; HUMANS; HYALURONIC ACID; INJECTIONS, INTRAVENOUS; MALE; MATERIALS TESTING; MUCOCILIARY CLEARANCE; PARTICLE SIZE; PERMEABILITY; POLYVINYL ALCOHOL; POVIDONE; RATS; RATS, WISTAR; RESPIRATORY MUCOSA; SURFACE PROPERTIES;

EID: 54949109737     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.07.004     Document Type: Article

References (37)

1. Wei N. Advances of breviscapine in clinical applications and its side-effects. China Pharm. 4 (2001) 144-146
2. Chen X.Y., Cui L., Duan X.T., Ma B., and Zhong D.F. Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration. Drug Metab. Dispos. 34 (2006) 1345-1352
3. Xiong F., Wang H., Cheng J., and Zhu J. Determination of scutellarin in mouse plasma and different tissues by high-performance liquid chromatography. J. Chromatogr. B 835 (2006) 114-118
4. He W., and Zeng F. Effect of breviscapine on ischemic cerebrovascular disease and its clinical investigation. Chin. J. Clin. Pharmacol. 18 (2002) 458-461
5. Hong H., and Liu G.Q. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci. 74 (2004) 2959-2973
6. Liu H., Yang X., Tang R., Liu J., and Xu H. Effect of scutellarin on nitric oxide production in early stages of neuron damage induced by hydrogen peroxide. Pharmacol. Res. 51 (2005) 205-210
7. Hao X., Cheng G., Yu J., He Y., An F., and Sun J. Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats. Pharmazie 60 (2005) 477-478
8. Patton J.S., Fishburn C.S., and Weers J.G. The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1 (2004) 338-344
9. Agu R.U., Ugwoke M.I., Armand M., Kinget R., and Verbeke N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir. Res. 2 (2001) 198-209
10. Laube B.L. The expanding role of aerosols in systemic drug delivery gene therapy and vaccination. Respir. Care 50 (2005) 1161-1174
11. Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc. Am. Thorac. Soc. 1 (2004) 315-320
12. Noone P.G., Regnis J.A., Liu X.R., Brouwer K.L.R., Robinson M., Edwards L., and Knowles M.R. Airway deposition and clearance and systemic Pharmacokinetics of amiloride following aerosolization with an ultrasonic nebulizer to normal airways. Chest 112 (1997) 1283-1290
13. Newman S., Salmon A., Nave R., and Drollmann A. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma. Respir. Med. 100 (2006) 375-384
14. Jones S.A., Martin G.P., and Brown M.B. Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules. J. Pharm. Sci. 95 (2006) 1060-1074
15. Jones S.A., Martin G.P., and Brown M.B. Stabilisation of deoxyribonuclease in hydrofluoroalkanes using miscible vinyl polymers. J. Control. Release 115 (2006) 1-8
16. Liao Y.H., Brown M.B., Jones S.A., Nazir T., and Martin G.P. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers. Int. J. Pharm. 304 (2005) 29-39
17. Lim S.T., Martin G.P., Berry D.J., and Brown M.B. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J. Control. Release 66 (2000) 281-292
18. Chang Q., Zuo Z., Chow M.S.S., and Ho W.K.K. Difference in absorption of the two structurally similar flavonoid glycosides hyperoside and isoquercitrin in rats. Eur. J. Pharm. Biopharm. 59 (2005) 549-555
19. Grenha A., Grainger C.I., Dailey L.A., Seijo B., Martin G.P., Remuñán-López C., and Forbes B. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur. J. Pharm. Sci. 31 (2007) 73-84
20. Zhang H.Y., Ping Q.N., Guo J.X., and Cao F. Pharmacokinetics of breviscapine and its (-cyclodextrin complex in rats. Acta Pharm. Sinica 40 (2005) 563-567
21. Vehring R. Pharmaceutical particle engineering via spray drying. Pharm. Res. 25 (2008) 999-1022
22. Seville P.C., Li H.Y., and Learoyd T.P. Spray-dried powders for pulmonary drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 24 (2007) 307-360
23. Sakagami M., Sakon K., Kinoshita W., and Makino Y. Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. J. Control. Release 77 (2001) 117-129
24. Sakagami M., Kinoshita W., Sakon K., Sato J., and Makino Y. Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation. J. Control. Release 80 (2002) 207-218
25. Usmani O.S., Biddiscombe M.F., and Barnes P.J. Regional lung deposition and bronchodilator response as a function of (2-agonist particle size. Am. J. Respir. Crit. Care Med. 172 (2005) 1497-1504
26. Wang C., Liu X.B., Quan L.H., Liu C.Y., and Liao Y.H. Pulmonary delivery of traditional Chinese medicines. World Sci. Technol. Mod. Tradit. Chin. Med. 9 (2007) 59-64
27. Florea B.I., Thanou M., Junginger H.E., and Borchard G. Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation. J. Control. Release 110 (2006) 353-361
28. Florea B.I., Cassara M.L., Junginger H.E., and Borchard G. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J. Control. Release 87 (2003) 131-138
29. Forbes B., and Ehrhardt C. Human respiratory epithelial cell culture for drug delivery applications. Eur. J. Pharm. Biopharm. 60 (2005) 193-205
30. Yamamoto H., Kuno Y., Sugimoto S., Takeuchi H., and Kawashima Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J. Control. Release 102 (2005) 373-381
31. Amidi M., Pellikaan H.C., de Boer A.H., Crommelin D.J.A., Hennink W.E., and Jiskoot W. Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery. Eur. J. Pharm. Biopharm. 68 (2008) 191-200
32. Morimoto K., Metsugi K., Katsumata H., Iwanaga K., and Kakemi M. Effects of low-viscosity sodium hyaluronate preparation on the pulmonary absorption of rh-insulin in rats. Drug Dev. Ind. Pharm. 27 (2001) 365-371
33. Surendrakumar K., Martyn G.P., Hodgers E.C.M., Jansen M., and Blair J.A. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J. Control. Release 91 (2003) 385-394
34. A. Quader, Spray Dried Formulations for the Pulmonary Delivery of Peptides and Proteins. Ph.D. Thesis, University of London, 2004.
35. Liao Y.H., Jones S.A., Forbes B., Brown M.B., and Martin G.P. Hyluronan: pharmaceutical characterization and drug delivery. Drug Deliv. 6 (2005) 327-342
36. Schlesinger R.B. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J. Toxicol. Environ. Health 15 (1985) 197-214
37. Smart J.D. The basics and underlying mechanisms of mucoadhesion. Adv. Drug Deliv. Rev. 57 (2005) 1556-1568